seed
Stage
1
Investors
About
Ridge Biotechnologies develops AI-driven enzyme and targeted drug design technologies to create precision medicines, including engineered enzymes, bioconjugates, and linker systems for safer and more effective therapeutics.
Explore Ridge Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.